Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Total article views   HTML views PDF downloads Totals
15,610 Dovepress* 15,610+ 3,462 19,072
Totals 15,610 3,462 19,072
*Since 12 April 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 0 6

View citations on Google Scholar